- Open Access
Anti-malarial activities of Andrographis paniculata and Hedyotis corymbosa extracts and their combination with curcumin
© Mishra et al; licensee BioMed Central Ltd. 2009
- Received: 06 October 2008
- Accepted: 12 February 2009
- Published: 12 February 2009
Herbal extracts of Andrographis paniculata (AP) and Hedyotis corymbosa (HC) are known as hepato-protective and fever-reducing drugs since ancient time and they have been used regularly by the people in the south Asian sub-continent. Methanolic extracts of these two plants were tested in vitro on choloroquine sensitive (MRC-pf-20) and resistant (MRC-pf-303) strains of Plasmodium falciparum for their anti-malarial activity.
Growth inhibition was determined using different concentrations of these plant extracts on synchronized P. falciparum cultures at the ring stage. The interactions between these two plant extracts and individually with curcumin were studied in vitro. The performance of these two herbal extracts in isolation and combination were further evaluated in vivo on Balb/c mice infected with Plasmodium berghei ANKA and their efficacy was compared with that of curcumin. The in vivo toxicity of the plant derived compounds as well as their parasite stage-specificity was studied.
The 50% inhibitory concentration (IC50) of AP (7.2 μg/ml) was found better than HC (10.8 μg/ml). Combination of these two herbal drugs showed substantial enhancement in their anti-malarial activity. Combinatorial effect of each of these with curcumin also revealed anti-malarial effect. Additive interaction between the plant extracts (AP + HC) and their individual synergism with curcumin (AP+CUR, HC+CUR) were evident from this study. Increased in vivo potency was also observed with the combination of plant extracts over the individual extracts and curcumin. Both the plant extracts were found to inhibit the ring stage of the parasite and did not show any in vivo toxicity, whether used in isolation or in combination.
Both these two plant extracts in combination with curcumin could be an effective, alternative source of herbal anti-malarial drugs.
- Plant Extract
- Herbal Extract
- Herbal Drug
- Serum Glutamic Pyruvic Transaminase
The effective anti-malarial activity of the two plant-based drugs, quinine and artemisinin, has generated much interest to explore other plant resources for their possible anti-malarial efficacy. Malaria is still an ever-continuing epidemic that claims thousands of lives in the Indian sub-continent each year and the majority of the malarial deaths are due to Plasmodium falciparum. During last decade, several fundamental researches have been conducted to explore anti-malarial activity of many plants, including Citrus cinensis, Carcia papaya, Swertia chirata, Bidens pilosa, Piper sarmentosum, Tinospora corpa and many others . Curcumin, a natural polyphenolic compound (isolated from root of Curcuma longa, turmeric) apart from its diverse pharmacological properties including anticarcinogenic , is also known to have anti-protozoan activity . Further, its efficacy has been evaluated and advocated in a combination therapy with artemisinin (derived from plant Artemisia annua) to control malaria . Combination drug regimens have become the practice of choice because of their increased therapeutic efficacy over monotherapy and the other benefits include decreased cytotoxicity, delay or prevention of the development of drug resistance .
In the present study, Andrographis paniculata (Acanthaceae) and Hedyotis corymbosa (Rubiaceae) were selected for evaluation of their anti-malarial activities, as their traditional uses as anti-pyretic drugs are common among different tribal population in south-east India. The ethno-pharmacological properties of A. paniculata are well documented and several in vitro and in vivo studies describe its anti-cold, anti-hepatotoxic, anti-urothelial and anti-hepato-toxic properties [9–11]. Some studies have also reported its anti-malarial properties [12–15]. In contrast, other than a single study  that documents the hepato-protective activity of H. corymbosa, there is no report of anti-malarial activity.
This report demonstrates the anti-malarial properties of these two herbal extracts, individually and in combination on Plasmodium falciparum in vitro and on Plasmodium berghei in vivo; and compares their activity in combination with curcumin. The stage-specific activity of these extracts and their in vivo toxicity has also been investigated. The anti-malarial activities exerted by these two plant extracts were found comparable with that of curcumin.
Plant materials and chemicals
Preparation of plant extract
The aerial parts of the plants were crushed in liquid nitrogen to fine powder. An aliquot of 5.0 gram of pulverized material from each plant was stirred with 98% methanol (50 ml) at 4°C over night and filter-sterilized using cellulose acetate membranes (0.45 μm; Millipore Corporation, Bedford, MA). Individual plant extracts were evaporated to dryness at 37°C by the help of a Speed Vac (Model 7811001, Labconco, USA) and the residue was stored in aliquots at 4°C until tested. Usually, a 0.4% yield of extract was obtained invariably from each of the plants.
Parasite strain and in vitro culture
Two strains of P. falciparum, one sensitive to chloroquine (MRC-pf-20) and the other resistant (MRC-pf-303) were obtained from the Malaria Parasite bank, maintained by the National Institute of Malaria Research, New Delhi, India. The cultures have been maintained in the laboratory using the candle jar method  in human red blood cells (blood type O+) at a 5% haematocrit in RPMI 1640 medium with 25 mM HEPES, 0.2% sodium bicarbonate and 15% human AB+ serum. The ANKA strain of P. berghei was procured as a generous gift from the Tata Institute of Fundamental Research, Mumbai, India.
Determination of dose response of A. paniculata and H. corymbosa extracts on in vitro grown P. falciparum
Percent (%) inhibition of schizonts by extracts of Andrographis paniculata (AP) and Hedyotis corymbosa (HC) in choloroquine sensitive (MRC-pf-20) and resistant strains (MRC-pf-303) of Plasmodium falciparum.
Concentration of drug (μg/ml)
Chloroquine sensitive (MRC-pf-20)
Chloroquine resistant (MRC-pf-303)
15.3 ± 1.49
11.6 ± 0.6
33.6 ± 2.1
28.13 ± 0.6
52.6 ± 1.01
50.7 ± 1.3
70.5 ± 1.9
66.1 ± 0.8
85.3 ± 1.5
81.6 ± 1.8
96. 8 ± 0.7
94.8 ± 0.8
8.3 ± 1.2
6.7 ± 0.7
20.2 ± 0.8
17.5 ± 1.4
39.3 ± 0.9
33.1 ± 0.6
61.7 ± 1.1
59.8 ± 2.0
82.4 ± 1.9
77.3 ± 1.3
91.8 ± 0.6
88.7 ± 0.7
97.5 ± 0.9
96.9 ± 0.05
In vitro interaction of plant extracts and their combination with curcumin
Drug interaction studies were performed as described  on chloroquine resistant isolates of P. falciparum (MRC-pf-303). The IC50 value of pure curcumin (CUR) was calculated as 6.6 μg/ml . For interaction studies, putative drug solutions of A. paniculata (AP), H. corymbosa (HC) and curcumin (CUR) were diluted with serum-free culture medium to initial concentrations of 80 times the predetermined IC50 (Table 1). These solutions were combined in the ratios of 1:5, 1:2, 2:1 and 5:1 for each interacting trial (AP+HC, AP+CUR and HC+CUR). Similarly combinations of three putative drugs (AP+HC+CUR) were prepared in three ratios (3:2:1, 2:1:3, 1:3:2). The solutions were then introduced in duplicate into 96-well titer plates with serial double dilutions from their respective stock to ensure different concentrations of single and combined drug solutions in each well along with parasites at their ring stage. The plates were incubated at 37°C in the candle jar. Finally, IC50 values of individual putative drugs and their combinations were determined. For data interpretation, IC50 values of these drugs in combination were expressed as fractions of the IC50 of the extracts alone normalized to 1. Isobolograms were constructed by plotting the IC50 of one extract against the IC50 of the other for each of the four combinations. To express level of interactions numerically, results were represented as the sum of the fractional inhibitory concentrations (sum FIC). FIC = IC50 of extract A in mixture/IC50 of extract A alone + IC50 of extract B in mixture/IC50 of extract B alone. Sum FIC values were considered to be the indication of the type of interaction between putative drugs and represented as synergy for the value < 0.5, 0.5 to 1 as addition; 1 to 2 as indifferent interaction and > 2 antagonisms.
In vivo toxicity assay
Mice (Balb/c, 25 g ± 4 g) were used and randomly distributed into five groups (n = 4/group) for this study. They were kept in filter top cages and housed in environmentally controlled rooms (temperature, 22 ± 0.8°C; relative humidity 30 to 50%) with a 12 h day and night light cycle. Food and water were provided ad libitum. Three groups of mice were given intraperitoneal injections (50 mg/kg of body weight) of the drugs AP, HC and (AP + HC) respectively and a group of mice was given DMSO (0.01%) as control experiment, while the other control group was kept without any treatment. Mice were observed frequently at 8–10 h intervals for any discomfort until 72 h post-injection. At the end of three days (72 h), the body weight was recorded. Necropsy was performed and the livers and kidneys were removed for histopathological analysis. For blood analysis, animals were bled through heart puncture and the samples were analysed for Serum Glutamic Pyruvic Transaminase (SGPT) and Serum Glutamic Oxaloacetic Transaminase (SGOT) enzymes by the method described earlier . Hematological analyses were performed from the whole blood by fully auto blood counter (RMS-Hestia 60, Chandigarh, India).
Stage specific inhibitory effect of herbal extracts on chloroquine resistant strains of P. falciparum
The stage-specific inhibitory effect of herbal extracts was studied by following a published protocol . Briefly, ring-infected RBCs (0 to 5 h old), trophozoite-infected RBCs (20 to 25 h old), and schizont-infected RBCs (37 to 42 h old) were incubated in presence of both the plant extracts at their IC90 concentrations (60 μg/ml) for 5–6 hour at 37°C. Cells were washed with incomplete medium to remove the drugs after incubation and were then further maintained in regular culture condition. Untreated synchronous controls were processed in the same way as the treated cultures. After 24 hours, blood smears were prepared and JSB-stained. Parasitaemia was established on 2,000 cells by counting number of new rings that formed during the second erythrocytic cycle for both the plant extracts.
In vivo study on anti-malarial activities of the plant extracts
The in vivo anti-malarial activity of A. paniculata, H. corymbosa and their combinations were evaluated and compared with that of curcumin by a series of tests. Mice, (Balb/c, 28 g ± 4 g) were randomly distributed into five groups, each group comprising of four animals. The blood of a donor mouse with 30% parasites at old trophozoite stage was collected in a heparinized syringe. The parasitized blood was diluted in physiological saline solution (0.9% NaCl) to a density of 5 × 107 RBCs/ml.
Mice of all five groups were inoculated intra-peritoneally with 0.2 ml of the parasite suspension (1 × 107 parasites) of P. berghei ANKA on day 1. The test compounds (AP, HC, AP+ HC and CUR) were dissolved in DMSO along with serum free medium to make desired concentrations (7 mg/kg of body weight) and were injected intra-peritoneally to four individual groups of animals designated as AP, HC, AP +HC and CUR, respectively. Drug treatments were initiated 24 h prior to the parasite challenge (day 0). The control experiment, without any drug treatment, was performed simultaneously. Drug treatments were continued on a daily basis until the death of mice noted among the control group. Starting from day-4 of post-infection, on every alternate day, the level of parasitaemia in each group of mice was determined from tail-blood. The animal experiments complied with all relevant guidelines and institutional policies on animal ethics.
Growth inhibition assay of P. falciparum using A. paniculata and H. corymbosa extracts
The plant extracts of AP (A. paniculata) and HC (H. corymbosa) manifested significant activities against both the resistant and sensitive strains of P. falciparum. The percentage of growth inhibition was determined using different concentrations of plant extracts (Table 1). The results were compared to that of the parasites grown in control wells (without treatment of herbal extracts). Maximum growth inhibition (97% in chloroquine-sensitive and 95% in chloroquine-resistant strains) was obtained with AP at a concentration of 62.5 μg/ml. The concentration above this (125, 250 and 500 μg/ml) exhibited total growth inhibition of the parasites at ring stage for both the strains. Whereas HC showed its maximum inhibitory effect (97%) at a concentration of 125 μg/ml in both chloroquine-sensitive and -resistant strains (Table 1). Higher concentrations (250 and 500 μg/ml) of HC caused total inhibition of the parasite at ring stage. The IC50 values of these plants were calculated and found to be7.2 μg/ml and 10.8 μg/ml for AP and HC, respectively.
In vitro drug interactions
Sum FIC50 of extracts of Andrographis paniculata (AP), Hedyotis corymbosa (HC) and curcumin in different combinations
0.8 ± 0.06
0.8 ± 0.04
0.84 ± 0.04
1.02 ± 0.1
0.27 ± 0.03
0.22 ± 0.04
0.44 ± 0.03
0.34 ± 0.01
0.45 ± 0.05
0.47 ± 0.04
0.5 ± 0.04
0.51 ± 0.04
Determination of stage-specific effectiveness of the test plant extracts
The stage-specific effectiveness of AP and HC were determined by applying these putative drugs individually at their IC90 concentrations in three different developmental stages, namely, ring-, trophozoite- and schizont-stage of P. falciparum, with respective controls. Positive inhibitory effects with both the extracts were found only with ring-stage parasites. The other treatment groups (trophozoites and schizonts) exhibited normal development as the controls. The growth inhibition of the parasites at ring stage was found to be permanent, as the rings underwent lyses and lost the cellular architecture with extension of incubation period from 24 h to 48 h.
In vivo toxicity study
Follow-up evaluations of herbal drugs both in isolation (AP, HC) and combination (AP+HC) to test the in vivo toxicity in mice showed no obvious toxic side effects and treated mice were found healthy and normal with no record of weight loss, hair loss, allergy or any other symptoms of discomfort. The hematological parameters between the experimental and control sets were the same without any major changes. Sections of liver and kidney did not show significant changes on administration of plant extracts. Liver sections from the control mice as well as from the treated mice that were administered AP, HC, AP + HC showed a normal pattern of hepatic and biliary parenchyma. All the blood parameters remained within the normal range. The levels of SGOT and SGPT in both control as well as in drug treated mice were found almost the same (SGOT, 62.8 ± 5.3; SGPT, 78.3 ± 7.5 U/ml).
In vivo study on anti-malarial activities of herbal extracts
The present study assessed the anti-malarial properties of two Indian traditional plants, A. paniculata and H. corymbosa, individually and in combinations and compared their activity with curcumin.
Traditional uses of A. paniculata extracts in the Indian medicine particularly in the treatment of various liver disorders are common [4, 23–25]. Earlier studies have also demonstrated the antipyretic  and anti-diarrheal  properties of this plant. The role of Andrographolides, one of its major phytoconstituents has been reported to have inhibitory effect on the rat and human hepatic cytochrome P450  and the alpha-glucosidase and alpha-amylase enzymes that cause type 2 diabetes . Few reports are also available on the anti-malarial activity of the plant A. paniculata[3, 4, 12–15]. However, exploitation of drug potentials of H. corymbosa is limited, except one, which document the hepato-protective activity of this plant . This lacuna prompted us to explore the possibility.
Both chloroquine-sensitive (MRC-pf-20) and -resistant (MRC-pf-303) strains of P. falciparum treated with AP and HC, exhibited arrested growth, The IC50 values were calculated and found 7.2 μg/ml for AP and 10.8 μg/ml for HC. Maximum growth inhibition (95%) of P. falciparum was observed at 62.5 μg/ml and 125 μg/ml concentrations of AP and HC extracts, respectively (Table 1), in both MRC-pf-20 and MRC-pf-303. The activity was further confirmed by a study that showed the parasite stage-specificity of the plant extracts. The herbal extracts were found to arrest the ring stages, which did not revive even after the drugs were withdrawn. These observations confirm that these two plant extracts exert permanent inhibitory activity on the ring stage of the parasite. Further, results of in vivo toxicity study indicated no toxicity associated with the use of these extracts in mice system.
The anti-malarial activity of AP and HC was compared with the recently described herbal drug curcumin. Curcumin shares an almost common range of anti-malarial activity (IC50, 6.6 μg/ml) with that of AP (IC50 = 7.2 μg/ml) and HC (IC50 = 10.8 μg/ml) and was, therefore, taken for combination studies. Isobologram analysis is the most accepted and rigorous method for evaluating drug interactions in combination mixtures and employed in other studies, e.g. cancer , tuberculosis  inflammation  or malaria [7, 8, 33, 34]. Interaction studies for both the plant extracts among themselves (AP+HC) and with curcumin individually (AP+CUR, HC+CUR), at four fixed ratios (1:5, 1:2, 2:1 and 5:1) were carried out in vitro on a chloroquine-resistant isolate of P. falciparum (MRC-pf-303). The study revealed the evidence of efficient additive activity between the two indigenous plants (AP+HC). The additiveness, resulting in sum FIC values less than 1 referred to increase of activity when drugs are used in combination. However, curcumin was found to be a potential combination partner with both the indigenous plants (AP and HC) in all four ratios as in both the combinations, the effect was found synergistic. Similar activity was also observed with the test compounds when studied in vivo. Mice treated with the combination of AP and HC showed better survivability compared to the groups that were treated individually with AP or HC.
The search of new compounds from plants is of course an important area of research for exploring new potential drugs for malaria. However, reliable data on the clinical pharmacology, efficacy and safety of such formulae are extremely scarce, preventing a responsible consideration of their potential benefits . Further, lack of awareness among people may worsen the situation particularly when the toxicity aspect of herbal drugs is overlooked. Still there is a need for continued efforts to discover new template molecule from herbal sources.
This study adds important information to the area of malaria research, which always is in need of alternative anti-malarial drugs and drug combinations to combat with the drug resistant parasites. Although it is premature to conclude at this stage that these herbal combinations can be used as effective anti-malarials, this finding provides a foundation for further exploration of a new effective herbal drug or drug combination with curcumin for protection from the development of resistance among malarial parasites.
We are greatly indebted to Institute of Life Sciences for the facilities. We thank Dr. Dipak Kumar Sahoo and Mr. Kinshuk Chandra Nayak for their sincere help in the preparation of the figures. The DST project to KM (SR/FT-L-145/2005) and DBT confocal project to ND (BT/PR-5998/INF/22/028/2005) supported this research is gratefully acknowledged. We thankfully acknowledge the contributions of Dr. C.R. Pillai and National Institute of Malaria Research particularly for the parasite strains. We thank Red Cross Blood Bank, MKCG Medical College, Berhampur for helping us in procuring human blood serum for the parasite culture work. The authors thank Prof. Amita Pal, Senior Professor, Bose Institute, Kolkata, for critical reading of the manuscript. We sincerely acknowledge the help and support we have received from Dr. B. Ravindran, Director, Institute of Life Sciences, Bhubaneswar.
- Bhat GP, Surolia N: In vitro antimalarial activity of extracts of three plants used in the traditional medicine of India. Am J Trop Med Hyg. 2001, 65: 304-308.PubMedGoogle Scholar
- Krettli AU, Andrade-Neto V, Brandao ML, Ferrari WMS: The search for new antimalarial drugs from plants used to treat fever and malaria or plants randomly selected: a review. Mem Inst Oswaldo Cruz. 2001, 96: 1033-1042.View ArticlePubMedGoogle Scholar
- Rahman NNNA, Furuta T, Kojima S, Tabane K, Ali-Mohd M:In vitro and in vivo study revealed that malarias medicinal plants, Piper sarmentosum, Andrographis paniculata and Tinospora crispa produce considerable antimalarial effect. J Ethnopharmacol. 1999, 64: 249-254. 10.1016/S0378-8741(98)00135-4.View ArticleGoogle Scholar
- Saxena S, Pant N, Bhakuni RS: Antimalarial agents from plant sources. Cur Sci. 2003, 85: 1314-1326.Google Scholar
- Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB: Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007, 28: 1765-1773. 10.1093/carcin/bgm123.View ArticlePubMedGoogle Scholar
- Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN: Curcumin for malaria therapy. Biochem Biophys Res Commun. 2005, 326: 472-474. 10.1016/j.bbrc.2004.11.051.View ArticlePubMedGoogle Scholar
- Nandakumar DN, Nagaraj VA, Vathsala PG, Rangarajan P, Padmanaban G: Curcumin-artemisinin combination therapy for malaria. Antimicrob Agents Chemother. 2006, 50: 1859-1860. 10.1128/AAC.50.5.1859-1860.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Fivelman QL, Adagu IS, Warhurst DC: Modified fixed-ratio isobologram method for in vitro interaction between atovaquone and proguanil or dihydroartemisinin against drug resistant strain of Plasmodium falciparum. Antimicrob Agents Chemo. 2004, 48: 4097-4102. 10.1128/AAC.48.11.4097-4102.2004.View ArticleGoogle Scholar
- Caceres DD, Hancke JL, Burgos RA, Wikman GK: Prevention of common colds with Andrographis paniculata dried extract: A pilot double-blind trial. Phytomedicine. 1997, 4: 101-104.View ArticlePubMedGoogle Scholar
- Kapil A, Koul IB, Banerjee SK, Gupta BD: Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem Pharmacol. 1993, 46: 182-185. 10.1016/0006-2952(93)90364-3.View ArticlePubMedGoogle Scholar
- Sheeja K, Kuttan G: Protective effect of Andrographis paniculata and andrographolide on cyclophosphamide-induced urothelial toxicity. Int Cancer Therapy. 2006, 5: 244-251. 10.1177/1534735406291984.View ArticleGoogle Scholar
- Najib Nick A, Furuta T, Kojima S, Takane K, Ali Mohd M: Antimalarial activity of extracts of Malayasian medicinal plants. J Ethnopharmacol. 1999, 64: 249-254. 10.1016/S0378-8741(98)00135-4.View ArticleGoogle Scholar
- Siti Najilaa MJ, Noor Raina A, Mohamad Kamelb AG, Syed Zahirb SI, Khozirahd S, Lokman Hakimc S, Zakiaha I, Azizold AK: The screening of extracts from Goniothalamus scortechinii, Aralidium pinnatifidum and Andrographis paniculata for anti-malarial activity using the lactate dehydrogenase assay. J Ethnopharmacol. 2002, 82: 239-242. 10.1016/S0378-8741(02)00183-6.View ArticleGoogle Scholar
- Dua VK, Ojha VP, Roy R, Joshi BC, Valecha N, Usha Devi C, Bhatnagar MC, Sharma VP, Subbarao SK: Anti-malarial activity of some xanthones isolated from the roots of Andrographis paniculata. J Ethnopharmacol. 2004, 95: 247-251. 10.1016/j.jep.2004.07.008.View ArticlePubMedGoogle Scholar
- Misra P, Pal NL, Guru PY, Katiyar JC, Srivastava V, Tandon JS: Antimalarial activity of Andrographis paniculata (Kalmegh) against Plasmodium berghei NK 65 in Mastomys natalensis. Int J Pharmacog. 1992, 30: 263-274. 10.3109/13880209209054010.View ArticleGoogle Scholar
- Sadasivan S, Latha PG, Sasikumar JM, Rajashekaran S, Shyamal S, Shine VJ: Hepatoprotective studies on Hedyotis corymbosa (L.) Lam. J Ethnopharmacol. 2006, 106: 245-249. 10.1016/j.jep.2006.01.002.View ArticlePubMedGoogle Scholar
- Trager W, Jensen B: Human malaria parasites in continuous culture. Science. 1976, 193: 673-675. 10.1126/science.781840.View ArticlePubMedGoogle Scholar
- Lambros C, Vanderberg JP: Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979, 65: 418-420. 10.2307/3280287.View ArticlePubMedGoogle Scholar
- JSB Staining protocol. [http://www.malariasite.com/malaria/staining_techniques.htm]
- Wiesner J, Henschker D, Hutchinson DB, Beck E, Jomma H: In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin. Antimicrob Agents Chemother. 2002, 46: 2889-2894. 10.1128/AAC.46.9.2889-2894.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Reitman S, Frankel S: A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957, 28: 56-PubMedGoogle Scholar
- Sinou V, Grellier P, Schrével J: In vitro and in vivo inhibition of erythrocytic development of malarial parasite by docetaxel. Antimicrob Agents Chemother. 1996, 40: 358-361.PubMed CentralPubMedGoogle Scholar
- Handa SS, Sharma A: Hepatoprotective activity of andrographolide against galactosamine and paracetamol intoxication in rats. Ind J Med Res. 1990, 92B: 284-292.Google Scholar
- Sharma A, Singh RT, Sehgal V, Handa SS: Antihepatotoxic activity of some plants used in herbal formulation. Fitotherapia. 1991, 62: 131-138.Google Scholar
- Saraswat B, Visen PKS, Patnaik GK, Dhawan BN: Effect of andrographolide against galactosamine induced hepatotoxicity. Fitotherapia. 1995, 66: 415-420.Google Scholar
- Madhav S, Tripathi H, Tanden C, Mishra SK: Analgesic, anti-pyretic and anti-ulcerogenic effects of andrographolide. Ind J Pharm Sci. 1995, 57: 121-125.Google Scholar
- Gupta S, Choudhury MA, Yadav JNS, Srivastava V, Tandan JS: Anti-diarrhoeal activity of diterpenes of Andrographis paniculata (Kalmegh) against Escherichia coli enterotoxin in in vivo models. Int J Crude Drug Res. 1990, 28: 273-283.View ArticleGoogle Scholar
- Pethkong D, Martin H, Abadie C, Bonet A, Heyd B, Mantion G, Richert L: Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide. J Ethnopharmacol. 2008, 115: 432-440. 10.1016/j.jep.2007.10.013.View ArticleGoogle Scholar
- Subramanian R, Asmawi MZ, Sadikun A: In vitro alpha glucosidase and alpha amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochem Pol. 2008, 55: 391-398.Google Scholar
- Zhao L, Guillaume Wientjes M, Jessi L: Evaluation of combination chemotherapy. Clin Cancer Res. 2004, 10: 7994-8004. 10.1158/1078-0432.CCR-04-1087.View ArticlePubMedGoogle Scholar
- Desso M, Ouattara L, Cherif AM, Bouzid SA, Haller L, Fernex M: Experimental in vivo efficacy study on the interaction of epiroprim plus isoniazid against Mycobacterium tuberculosis. Int J Exp Clin Chemother. 2001, 47: 123-127.Google Scholar
- Miranda HF, Puig MM, Prieto JC, Pinardi G: Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain. 2006, 121: 22-28. 10.1016/j.pain.2005.11.012.View ArticlePubMedGoogle Scholar
- Mishra LC, Bhattacharya A, Bhasin VK: Antimalarial interactions between artemisinin and triclosan or ketoconazole combinations against blood stages of Plasmodium falciparum in vitro. Am J Trop Med Hyg. 2007, 76: 497-501.PubMedGoogle Scholar
- Gupta S, Thapar MM, Wernsdorfer WH, Bjorkman A: In vitro interaction of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob Agents Chemother. 46: 1510-1515. 10.1128/AAC.46.5.1510-1515.2002.Google Scholar
- Rath K, Taxis K, Walz G, Gleiter CH, Li S, Heide L: Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). Am J Trop Med Hyg. 2004, 70: 128-132.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.